Russia BE Study [Regulatives / Guidelines]

posted by Beholder  – Russia, 2020-10-03 19:51 (59 d 12:27 ago) – Posting: # 21967
Views: 1,447

Hi Brus!

An idea visited my mind. The permission for clinical trial in Russia does not contain the information regarding analytical/PK part of the study at all. It talks only about clinical part of BEQ project. So in Russia we can say that clinical study = clical part of BEQ study. So it means that only clinical part has to be conducted in Russia. Again indirect prove but only this we have. Hope it helps.

Best regards
Beholder

Complete thread:

Activity
 Admin contact
21,226 posts in 4,427 threads, 1,482 registered users;
online 6 (0 registered, 6 guests [including 3 identified bots]).
Forum time: Wednesday 07:18 CET (Europe/Vienna)

A big data-analyst is an expert
in producing misleading conclusions from huge datasets.
It is much more efficient to use a statistician,
who can do the same with small ones.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5